Abstract 13223: Influence of Troponin Elevation on Short- And Long-Term Mortality in Severe Sepsis and Septic Shock
Background: Troponin-T (TnT) elevation is common in severe sepsis and septic shock, but the impact on mortality and other clinical outcomes remains uncertain.
Methods: This was a retrospective review of adult patients with severe sepsis and septic shock admitted to all the intensive care units (ICU) at Mayo Clinic, Rochester from January 2012 to December 2014. Patients with congenital heart disease or pre-existing moderate or greater valvular disease were excluded. TnT elevation was defined as initial TnT ≥0.1 ng/mL or rise in 3- and 6-hour TnT ≥0.03 ng/mL. Primary outcomes included ICU, hospital, 28-day and 1-year mortality and secondary outcomes were need for and duration of non-invasive ventilation or invasive mechanical ventilation, ICU readmission, and ICU and hospital length of stay. Two-tailed p<0.05 was considered statistically significant.
Results: During this three-year period, TnT was measured in 372/765 patients (49%) with septic shock with TnT elevation noted in 329/372 (88%) patients. In patients with and without TnT elevation, initial TnT was 0.14±0.26 vs. 0.14±0.02 ng/mL, p=0.57 and peak TnT was 0.20±0.36 vs. 0.08±0.11 ng/mL, p<0.001. Severity of illness scores, laboratory values, vasopressor use, clinical parameters and medications were similar between patients with and without TnT elevation, except that patients with TnT elevation were older and had more frequent history of coronary atherosclerosis, chronic kidney disease, heart failure and atrial fibrillation (all p<0.05). There was no significant difference in ICU mortality [43 (13%) vs. 8 (19%), p=0.34] and hospital mortality [75 (23%) vs. 12 (28%), p=0.45] between patients with and without TnT elevation. Long-term follow-up of 220/329 (67%) patients showed no significant difference in 28-day mortality [97/216 (45%) vs. 1/4 (25%); p=0.63] or 1-year mortality [163/216 (75%) vs. 4/4 (100%); p=0.58]. There was no significant difference in any of the secondary outcomes between patients with and without elevated TnT (all p>0.05). There was no difference in mortality with increasing quartiles of peak TnT.
Conclusions: Troponin elevation is associated with older age and higher comorbidity burden, but does not predict mortality in patients with severe sepsis and septic shock.
Author Disclosures: S. Vallabhajosyula: Research Grant; Modest; CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), Bethesda MD, Intramural Grant, Critical Care Research Committee, Mayo Clinic, Rochester MN. J.C. Jentzer: None. J.B. Geske: None. K.B. Kashani: None. O. Gajic: None. R. Kashyap: None.
- © 2016 by American Heart Association, Inc.